Organic Process Research & Development
Article
(b) Welch, G. C.; Stephan, D. W. J. Am. Chem. Soc. 2007, 129, 1880−
fumehood. An aliquot was taken and the solvent removed
under reduced pressure. The resulting product was dissolved in
CDCl3 and a crude NMR spectrum acquired. For N-
benzylidene-tert-butylamine samples, the reaction mixture was
filtered through a 0.45 μm PTFE syringe filter, and 100 μL of
filtered reaction solution was combined with 6.8 μL of decane
(internal standard) and diluted to a total volume of 1 mL with
toluene. This sample was analyzed using GC-FID.
Catalyst Poisoning and Regeneration. Hydrogenation
Representative Procedure. The hydrogenation procedure
detailed above was followed, except that benzaldeyhde (2.5
μL, 0.025 mmol) was added to the imine solution prior to
catalyst addition. After 2 h under 100 atm of H2, the reactor was
brought back into the glovebox and a small aliquot removed for
GC analysis. Scavenger (0.05 mmol) was then added to the
solution and the reactor resealed and pressurized to 100 atm H2
for 2 h before standard workup and GC analysis. When
triethylsilane was employed as scavenger, B(C6F5)3 (1.28 mg,
0.0025 mmol) was introduced after the addition of
triethylsilane.
1881. (c) Spies, P.; Erker, G.; Kehr, G.; Bergander, K.; Frohlich, R.;
̈
Grimme, S.; Stephan, D. W. Chem. Commun. 2007, 47, 5072−5074.
(d) Stephan, D. W.; Erker, G. Angew. Chem., Int. Ed. 2010, 49, 46−76.
(e) Sumerin, S.; Schulz, F.; Atsumi, M.; Wang, C.; Nieger, M.; Leskela,
M.; Repo, T.; Pyykko, P.; Rieger, B. J. Am. Chem. Soc. 2008, 130,
14117−14119.
(6) Chase, P. A.; Welch, G. C.; Jurca, T.; Stephan, D. W. Angew.
Chem., Int. Ed. 2007, 46, 8050−8053.
(7) Chase, P. A.; Jurca, T.; Stephan, D. W. Chem. Commun. 2008,
1701−1703.
(8) (a) Stephan, D. W.; Greenberg, S.; Graham, T. W.; Chase, P.;
Hastie, J. J.; Geier, S. J.; Farrell, J. M.; Brown, C. C.; Heiden, Z. M.;
Welch, G. C.; Ullrich, M. Inorg. Chem. 2011, 50, 12338−12348.
(b) Rokob, T. A.; Hamza, A.; Stirling, A.; Soos, T.; Papai, I. Angew.
Chem., Int. Ed. 2008, 47, 2435−2438. (c) Eros, G.; Mehdi, H.; Papai,
I.; Rokob, T. A.; Kiraly, P.; Tarkanyi, G.; Soos, T. Angew. Chem., Int.
Ed. 2010, 49, 6559−6563. (d) Sumerin, V.; Chernichenko, K.; Nieger,
M.; Leskela, M.; Rieger, B.; Repo, T. Adv. Synth. Catal. 2011, 353,
̈
2093−2110. (e) Wang, H.; Frohlich, R.; Kehr, G.; Erker, G. Chem.
̈
Commun. 2008, 45, 5966−5968.
(9) Chase, P. A. Unpublished results.
(10) Stephan, D. W. Org. Biomol. Chem. 2012, 10, 5740−5746.
(11) Pedeutour, J. N.; Radhakrishnan, K.; Cramial, H.; Deffieux, A.
Macromol. Rapid Commun. 2001, 22, 1095−1123.
(12) (a) Blackwell, J. M.; Foster, K. L.; Beck, V. H.; Piers, W. E. J.
Org. Chem. 1999, 64, 4887−4892. (b) Blackwell, J. M.; Sonmor, E. R.;
Scoccitti, T.; Piers, W. E. Org. Lett. 2000, 2, 3921−3923. (c) Parks, D.
J.; Blackwell, J. M.; Piers, W. E. J. Org. Chem. 2000, 65, 3090−3098.
(d) Parks, D. J.; Piers, W. E. J. Am. Chem. Soc. 1996, 118, 9440−9441.
(13) These conditions were modeled after those reported in ref 7,
and conversions are comparable to those observed.
NMR Experiments Representative Procedure. To a small
vial was added 1b (25 mg, 0.039 mmol) in 0.8 mL of CD2Cl2
inside a nitrogen-filled glovebox. To this solution was added
benzaldehyde (4.8 μL, 0.047 mmol). The solution was then
added to a J. Young NMR tube, and the NMR spectra were
acquired. When complete reduction of benzaldehyde was
observed, triisobutylaluminium solution (25 wt % in toluene, 47
μL, 0.051 mmol) was then added, and the NMR spectra were
acquired.
(14) Aldrich research scale pricing as of March 14, 2013. http://
and 703087, respectively.
ASSOCIATED CONTENT
* Supporting Information
Characterization data for regeneration of poisoned catalysts and
product amines. This material is available free of charge via the
■
S
(15) Reaction of benzaldehyde with a variety of boron-based H2-
activated FLPs are known to give alkoxyborate complexes. These have
been found to be inactive as catalysts. See refs 5c and 6.
(16) (a) Diisobutylaluminium hydride (DIBAL-H) and Other Isobutyl
Aluminium Alkyls (DIBAL-BOT, TIBAL) as Specialty Organic Synthesis
Reagents, Azko-Nobel Technical Bulletin, OMS 06.388.03/April
2013. (b) Ashby, E. C.; Yu, S. H. J. Org. Chem. 1970, 35, 1034−1040.
(17) Neu, R. C.; Otten, E.; Lough, A.; Stephan, D. W. Chem. Sci.
2011, 2, 170−176.
(18) Park, S.; Brookhart, M. Organometallics 2010, 29, 6057−6064.
(19) Near quantitative conversion to the product amine is achieved at
0.5 mol % catalyst loading, 120 atm H2, and 100 °C under dry
conditions. See ref 8a.
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank NSERC of Canada for funding this work through an
Ideas to Innovationg Grant.
■
(20) Janiak, C.; Lassahn, P.-G. Macromol. Symp. 2006, 236, 54−62.
REFERENCES
■
(1) Vries, J. G. d.; Elsevier, C. J. The Handbook of Homogeneous
Hydrogenation; Wiley-VCH: Weinheim, Germany, 2007.
(2) (a) Brown, H. C.; Ramachandran, P. V. Sixty Years of Hydride
Reductions. In Reductions in Organic Synthesis; Abdel-Magid, A. F., Ed.;
ACS Symposium Series; American Chemical Society: Washington,
DC, 1996; Chapter 1, pp 1−30. (b) Crabtree, R. H. The
Organometallic Chemistry of the Transition Metals, 2nd ed.; John
Wiley & Sons: New York, 1994. (c) Dalko, P. I.; Moisan, L. Angew.
Chem., Int. Ed. 2004, 43, 5138−5175.
(3) (a) United States Pharmacopeia, 2010 standards. Pd, Pt, Ir, Rh
cannot exceed 100 μg/day for a 50 kg person. Boron limit is 10,000
μg/day. The United States Pharmacopeia; United States Pharmacopeial
Convention; Rockville, MD, 2010.
(4) Welch, G. C.; San Juan, R. R.; Masuda, J. D.; Stephan, D. W.
Science 2006, 314, 1124−1126.
(5) (a) Welch, G. C.; Cabrera, L.; Chase, P. A.; Hollink, E.; Masuda,
J. D.; Wei, P.; Stephan, D. W. Dalton Trans. 2007, 31, 3407−3414.
F
dx.doi.org/10.1021/op4000847 | Org. Process Res. Dev. XXXX, XXX, XXX−XXX